Erythrostemon gilliesii
Erythrostemon gilliesii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Erythrostemon gilliesii is a botanical species that has garnered scientific interest due to its diverse pharmacological potential. Research indicates that the seeds of this plant contain bioactive compounds, including galactomannan, which may play a role in therapeutic applications. Studies have specifically focused on the antiproliferative activities of its aqueous and ethanolic extracts. These preparations are being investigated for their ability to combat various cellular threats, most notably in the context of hepatocellular carcinoma. Consequently, understanding the chemical profile of its seeds provides vital insights into developing new treatments for liver cancer.
- Synonyms
- Poinciana Gilliesii · Prosopis Gillesii · 2 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Seed
Classification
Common Names
Erythrostemon gilliesii is a fascinating plant known by a wide variety of local and descriptive names. It is frequently referred to as Barba de boc or Barba de chivo, reflecting its unique physical characteristics. In certain regions, it carries the more poetic moniker of Bird of Paradise. Other common labels include Césalpinie de Gillies and the colloquial Lagaña de perro. This diversity of nomenclature highlights the plant's deep integration into different cultural landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Erythrostemon gilliesii is a botanical subject that has been cataloged under several different names throughout its taxonomic history. It is widely recognized by the synonym Caesalpinia gilliesii in many botanical records. The plant has also been referred to as Caesalpinia macrantha, reflecting different classifications used by researchers. Furthermore, it appears in literature under the names Poinciana gilliesii and Prosopis gillesii. Understanding these various synonyms is essential for accurately identifying the species across different scientific texts.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythrostemon gilliesii is a unique botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further falls into the order Fabales, showcasing its specific evolutionary lineage. As a member of the Fabaceae family, it shares structural characteristics with many other legumes. Ultimately, this species is defined by its scientific placement within the genus Erythrostemon.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrostemon |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrostemon gilliesii is a versatile plant species with a broad geographic presence across the African continent. Its distribution spans from the lush landscapes of East Tropical Africa, including Kenya and Tanzania, to the highlands of Northeast Tropical Africa in Ethiopia. Beyond the mainland, the species also thrives in the unique island environments of Macaronesia. Specifically, it can be found growing within the Canary Islands and the archipelago of Madeira. This wide-ranging habitat allows the plant to adapt to diverse ecological niches throughout these distinct regions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrostemon gilliesii is a versatile shrub characterized by its sturdy, self-supporting growth form. This resilient plant exhibits a remarkable range in size, depending on its specific environmental conditions. While it can exist as a small specimen as little as 0.15 meters tall, it is also capable of reaching a height of 5 meters. In certain optimal habitats, the species may even push its vertical limits to achieve a maximum height of 7 meters. This adaptability allows the plant to thrive across diverse landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Erythrostemon gilliesii, also known as Caesalpinia gilliesii, contains a specific polysaccharide known as galactomannan that demonstrates significant antiproliferative activity. Research indicates that this compound can effectively induce cell death in human hepatocellular carcinoma cell lines, such as HepG2, in a concentration-dependent manner. By arresting the cell cycle at the G2/M phase and inducing apoptosis, the substance targets the progression of cancer cells. In vivo studies further suggest that the extract helps reduce inflammatory markers and oxidative stress in liver tissues. These findings highlight the plant's potential as a promising therapeutic agent for the suppression of hepatocellular carcinoma.
Compounds
Erythrostemon gilliesii, also known as Caesalpinia gilliesii, serves as a natural source of a specific polysaccharide known as galactomannan. Extracted from the aqueous extract of its seeds, this galactomannan possesses a molecular weight of approximately 117.76 kDa and is composed primarily of mannose and galactose. Research indicates that this compound demonstrates significant antiproliferative potential against human hepatocellular carcinoma cell lines by inducing apoptosis and arresting the cell cycle. In vivo studies further suggest that it can effectively reduce inflammatory markers and serum transaminases in subjects with induced liver damage. Consequently, the galactomannan found within this plant shows great promise as a potential therapeutic agent for the suppression of hepatocellular carcinoma.
Conditions
Erythrostemon gilliesii, also referred to as Caesalpinia gilliesii, demonstrates significant therapeutic potential by treating hepatocellular carcinoma (HCC) through the use of its isolated galactomannan. This plant's extracts show a potent antiproliferative effect against the human HepG2 hepatocellular carcinoma cell line by inducing cell death and cell cycle arrest. Additionally, the plant exhibits strong anti-leishmanial activity against Leishmania major promastigotes. Research also indicates that its extracts can affect the macrophage cell line J774, showing toxicity at higher concentrations. Collectively, these findings highlight the plant's diverse medicinal applications in treating both cancerous and parasitic conditions.
Preparations
Erythrostemon gilliesii, also identified in the literature as Caesalpinia gilliesii, is prepared as an aqueous extract to isolate galactomannan for studying its antiproliferative potential against hepatocellular carcinoma. This specific aqueous preparation allows for the assessment of polysaccharides that can induce apoptosis and reduce inflammatory markers in vivo. Additionally, Erythrostemon gilliesii is prepared as ethanolic extracts to evaluate its medicinal properties against protozoan parasites. These ethanolic preparations were tested for their anti-leishmanial activity against Leishmania major promastigotes. Through these two distinct preparation methods, the plant demonstrates significant therapeutic potential in both cancer suppression and parasitic disease control.
Parts used
Erythrostemon gilliesii, also known as Caesalpinia gilliesii, contains specialized seeds that serve as a rich source of bioactive compounds. Researchers have successfully isolated a specific polysaccharide called galactomannan from the aqueous extract of these seeds. This particular component has demonstrated significant antiproliferative potential when tested against human hepatocellular carcinoma cell lines. In laboratory studies, the seed-derived galactomannan effectively induces cell death and arrests the cell cycle at the G2/M phase. Ultimately, these findings suggest that the seeds of this plant could be developed into promising therapeutic agents for suppressing liver cancer.